Tickerover
Healthcare

ALGN Stock Analysis

Align Technology, Inc. · current price $157.53 (-0.82% today)

Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
★★★
Average
📊

The six-pillar scorecard

Momentum
35
Losing steam
price trend
Growth
25
Barely growing
sales & profit growth
Quality
96
High quality
profitability & balance sheet
Valuation
90
Looks cheap
is the price fair?
Sentiment
45
Mixed views
analyst & crowd mood
Risk
51
Moderate risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
Near 52w highNear 52w high: 8888FundamentalsFundamentals: 8484Earnings qualityEarnings quality: 8484GrowthGrowth: 3030Relative strengthRelative strength: 4545VolumeVolume: 5050Analyst consensusAnalyst consensus: 5050
Margin profileWhat survives each step down the income statement.
GrossGross: 70.4%70.4%OperatingOperating: 18.2%18.2%NetNet: 10.0%10.0%Free cash flowFree cash flow: 15.3%15.3%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +1.7% vs estimate+2%2026-062026-03: +12.8% vs estimate+13%2026-032025-12: +10.8% vs estimate+11%2025-122025-09: +8.4% vs estimate+8%2025-09
👁

Hype Check

Reading ALGN’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading ALGN’s filings…

📣

Latest earnings

LAST EARNINGS Align Technology, Inc. (ALGN)

Latest earnings

EPS
$2.61 vs $2.41 est · +8.4% vs estimate BEAT
Revenue
$1.06B · +6.1% YoY
Stock reaction (1M)
-9.1%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
27.6×
Forward P/E
12.6×
PEG
0.75
Price / Sales
2.7×
Price / Book
2.7×
EV / EBITDA
11.2×
Analyst target
$208.60
Target range
$170.00 – $240.00
Implied upside
+32.4%
🩺

Financial health

Gross margin
70.4%
Operating margin
18.2%
Net margin
10.0%
FCF margin
15.3%
Return on equity
10.2%
Debt / equity
0.03
Revenue growth YoY
+4.3%
EPS growth YoY
-12.1%
📈

Technicals

$122.0052-week range$200.44
RSI (14)
37
50-day MA
$172.96
200-day MA
$170.06
ATR (14)
5.53
Beta
1.65
1-month return
-9.1%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$2.61$2.41+8.4%Beat
2025-12-31$3.29$2.97+10.8%Beat
2026-03-31$2.58$2.29+12.8%Beat
2026-06-30$2.64$2.60+1.7%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.06%
Beta
1.65
📰

Latest news on ALGN

🔗

Similar stocks in Healthcare

Frequently asked

What is ALGN's Quant Score?

Align Technology, Inc. (ALGN) currently has a TickerMover Quant Score of 50/100, rated ★★★ Average. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Align Technology, Inc. (ALGN) a buy?

TickerMover does not give buy or sell recommendations. ALGN scores 50/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ALGN's score updated?

ALGN's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for ALGN →